Guanfacine treatment of Alzheimer's disease.
Schlegel
J
J
Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland.
Mohr
E
E
Williams
J
J
Mann
U
U
Gearing
M
M
Chase
T N
TN
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D016316:Guanfacine; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D010648:Phenylacetates / Q000494:pharmacology*; D011897:Random Allocation
D000316:Adrenergic alpha-Agonists; D006146:Guanidines; D010648:Phenylacetates; D016316:Guanfacine